This evidence agrees with our result showing that CTPPU significantly decreased the expression levels of Akt and its downstream effectors, including p-GSK-3β, β-catenin, and c-Myc, which resulted in G1/S cell cycle arrest and inhibited the proliferation of NSCLC cells. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.